WOSH. Skin care with focus on the microbiome.

„All Natural Bodycare made for your Skin Microbiome”. With this slogan, we were particularly curious how WOSH’s Facial Bar would perform in our tests. To put the result first: We can confirm that WOSH is “Microbiome-friendly” certified for Standard 18.10, facial skin.
The special ingredient of WOSH Mineral Bars is Kisolite® Biogenic mineral powder (or Kisolite® BMP) from clay from the coastal region of British Columbia, Canada. It is found from former glacial impacts some 14,000 years ago. This almost magic ingredient, as WOSH itself puts it, raise our interest and we were really curious about how it would do in our test runs. We scrutinized WOSH in our quality test, balance test, vitality test, and diversity test, and we are happy to confirm that WOSH does not impact your facial skin microbiome and can call itself “Microbiome-friendly”, officially.
Have a look at their homepage and enjoy some interesting facts on the microbiome as well as their blog with recommendations for sustainable skin care, detox recipes, and much more to discover:
Sources / References:
1. Eslami-S Z, Majidzadeh-A K, et al. Microbiome and Breast Cancer: New Role for an Ancient Population. Front. Oncol. 2020, https://www.frontiersin.org/articles/10.3389/fonc.2020.00120/full
2. O'Connor H, MacSharry J, Bueso YF, Lindsay S, Kavanagh EL, Tangney M, et al. Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals? Disc Med. 2018, https://www.discoverymedicine.com/Hugh-OConnor/2018/09/resident-bacteria-in-breast-cancer-tissue-pathogenic-agents-or-harmless-commensals/
3. De Martel C, Ferlay J, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, https://pubmed.ncbi.nlm.nih.gov/?Db=pubmed&Cmd=ShowDetailView&TermToSearch=22575588
4. Fina F, Romain S, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer, 2001, https://pubmed.ncbi.nlm.nih.gov/?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11259092
5. Costantini L, Magno S, et al. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions. Sci Rep., 2018, https://pubmed.ncbi.nlm.nih.gov/?Db=pubmed&Cmd=ShowDetailView&TermToSearch=30442969
6. Jiménez E, de Andrés J, et al. Metagenomic analysis of milk of healthy and mastitis-suffering women. J Human Lactation, 2015, https://journals.sagepub.com/doi/abs/10.1177/0890334415585078
7. Kovács T, Mikó E, et al. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Sci Rep., 2019, https://www.nature.com/articles/s41598-018-37664-7
8. Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, et al. Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Prev Biomark., 2004, https://cebp.aacrjournals.org/content/13/4/567.short
9. de Moreno de LeBlanc A, Matar C, Theriault C, Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology., 2005, https://www.sciencedirect.com/science/article/abs/pii/S0171298505001014
10. Wallace B, Roberts A, et al. Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity. Chem Biol., 2015, https://www.sciencedirect.com/science/article/pii/S1074552115003257